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1. Introduction 
The major apolipoprotein of high density lipopro- 
teins (HDL), apolipoprotein A-I (apo A-I) is also a 
dominant apoprotein in rat chylomicrons [l-7], and 
the polar surface structures of the chylomicrons con- 
tribute a significant amount of material to circulating 
HDL [8,9]. Immunofluorescent studies on intestinal 
tissue [ 10,111, and data on lypmh lipoprotein labelling 
after administration of a radioactive amino acid pulse 
[12-l 51 indicate that the mucosa actively synthesizes 
apo A-I, apo A-IV and apo B, but only small amounts 
of C-peptides and apo E. The presence of apo A-I in 
human intestinal mucosa [ 161 has been correlated to 
an active synthesis of apo A-I in tissue culture of 
human small intestinal biopsies [ 171. 
In contrast apo E is the major apoprotein of nas- 
cent lipoproteins secreted by the liver, which also 
contain significant amounts of newly synthesized apo 
B and apo C, and much smaller proportions of apo A-I 
and A-IV than the intestinal lipoproteins [ 1 s-201. 
In the present study we examined the effects of 
thoracic duct drainage on the plasma lipid- and apo 
A-I levels. The purpose was to see if the drainage 
creates an apo A-I-deficient state, which could be a 
useful experimental model, or whether regulatory 
processes that compensate for the significant apo A-I 
loss could be revealed. 
2. Materials and methods 
Thoracic duct cannulations were performed on 
male white Sprague-Dawley rats weighing 250-300 g 
and the animals were treated after operation as 
described earlier [21]. The animals had a gastric fis- 
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tula through which they were fed 0.9-l .2 ml of corn 
oil in divided doses on the day after operation. On 
the third day they were not given any fat. All animals 
had a continuous infusion of 2.5 ml h-’ of 0.5% 
saline/2.5% glucose/O.Ofi% potassium chloride, but 
did not receive any protein or amino acids during the 
experimental period. 
Apo A-I was isolated from the HDL fraction ob- 
tained by zonal ultracentrifugation of rat plasma [22]. 
Apo A-I was separated from other apolipoproteins 
(A-IV, E and C) by gel filtration on screened Sephadex 
G-200, superfine [23] in 6 M guanidine hydrochloride 
(column size: 1.6 X 95 cm). The gel filtration was 
repeated twice in order to remove traces of apo E. 
Antiserum against apo A-I was raised in rabbits by 
multisite intracutaneous injections of 200 gg antigen 
in complete Freund’s adjuvant. The animals were 
boosted twice with 3 weeks’ interval. The antiserum 
was absorbed with rat LDL and albumin before use. 
The content of apo A-I in serum and lymph was 
determined by single radial immunodiffusion after 
previous delipidation of the samples with tetramethyl 
urea as described by Albers et al. [24]. Rat serum 
frozen at -70°C was used as standard. All apo A-I 
levels are given as per cent of the standard serum level. 
Cholesterol and triacylglycerols were determined 
by the Boehringer-Mannheim enzymatic kit methods, 
and phospholipids according to Bartlett [25]. Protein 
was determined by the method of Lowry et al. [26]. 
3. Results 
The apo A-I concentrations in serum were not 
lowered after thoracic duct drainage but were on 
average 28% higher than the concentrations in the 
control sera (table l), obtained from animals which 
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Table 1 
Plasma lipid- and apolipoprotein A-I levels in normal and 
thoracic duct cannulated rats 
Normals Thoracic drained 
rats 
Plasma apo-A-I 
concentration (%) 
Serum protein 
concentration (mg ml-’ ) 
APO-A-I concentration 
in lymph (%) 
Serum cholesterol 
(mg 100 ml-’ ) 
Serum lipidsoluble P 
olg ml-‘) 
Serum triacylglycerol S 
(mg 100 ml-’ ) 
97.1 i 4.4 125.9 k 5.5a 
(n= 7) (n= 11) 
70.8 * 1.8 53.3 * 3.3a 
29.9 i 1.9 
58.7 f 4.4 66.5 +_ 6.9ns. 
84.3 * 4.1 55.9 * 3.9” 
31.4 + 2.6 29.7 f 2.3”s. 
a Difference statistically significant (P < 0.01) as estimated 
by the Student’s f-test N.S. = not significant 
Measurements on the thoracic duct cannulated animals were 
performed 72 h after operation. Values for apolipoprotein 
A-I concentrations are expressed as % of the concentration in 
control serum 
had been fasted over night. Since the apo A-I concen- 
trations in lymph was 20-30% of that in the control 
sera, and the lymph flow during the experimental 
period (72 h) was 53-130 ml, the total apo A-I drain- 
age during the experimental period amounted to 2-4 
plasma volumes of apo A-I. Also the plasma choleste- 
rol level was somewhat increased in the cannulated 
rats (table l), whereas the triacylglycerol levels were 
about the same as in the fasted controls, and the plasma 
phospholipid levels were somewhat lowered. 
Although the animals were undoubtedly in a pro- 
.tein catabolic state during the experiment, since they 
did not receive protein or amino acids and lost 1 S-20 
g weight, the lymphatic apo A-I output did not de- 
crease with time (fig.1). The protein catabolic state, 
and the significant loss of protein by the lymph caused, 
however, a decrease in the levels of total plasma pro- 
tein (fig.2.) 
4. Discussion 
The main conclusion of the present study is, that 
a complete drainage of thoracic duct lymph does not 
lead to lowered plasma-apo A-I concentrations but 
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Fig.1. Time course for apolipoprotein A-I output in thoracic 
duct lymph. The apolipoprotein A-I output is expressed as 
multiples of the apo-A-I content in 1 ml control serum. Apo- 
A-I concentration is expressed as % of that in control serum. 
At each arrow 300 ~1 corn oil was fed through the stomach 
fistula. Values are from one representative animal. o----O, 
Apolipoprotein-A-I concentration; A----A, cumulative lymph 
flow; o-0, cumulative apolipoprotein-A-I output. 
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Fig.2. Time course for the output of lipids and total protein 
in thoracic duct lymph. Values are from the same animal as 
in tig.1. At each arrow 300 ~1 corn oil was fed throu_& the 
gastric fktula. m-----¤,Chloresterol; .---A, triacylglycerol; 
o---0, protein; l ---0, lipid phosphorus. 
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Table 2 Acknowledgements 
Total losses of protein and lipids in the lymph 
Drainage in 72 h 
thoracic duct cannulated rats 
Total lymph flow (ml) 
Protein (mg) 
Phospholipid (kg P) 
Cholesterol (mg) 
Triacylglycerol (mg) 
APO-A-I (ml serum) 
98.0 ? 10.5 
1294 I 167 
6212 + 857 
32.9 ? 3.9 
971 + 201 
29.1 + 3.5 
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duct cannulations were performed by Dr Britta 
Larsson. The work was supported by grants from the 
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3969 and 03X-4347), the Medical Faculty, University 
of Lund, Direktijr Albert PWssons Stiftelse fiir 
Medicinsk Forskning and Thorsten och Elaa Segerfalks 
Stiftelse. 
The losses of protein, lipids and apolipoprotein A-l in the 
lymph drained for 72 h after the thoracic duct cannulation 
were measured. The drainage of apolipoprotein A-l was cal- 
culated as ‘ml of control serum cleared from apolipoprotein 
A-l’ as follows: Total lymph flow in 72 h (ml) X lymph apo- 
lipoprotein A-I concentration as % of that in control serum 
x l/l00 
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